Canakinumab

retired
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.2106
Version
20220729
PublisherClinical ArchitectureDate2023-06-21T18:16:37-04:00Purpose

(Clinical Focus: This set of values contains terms related to canakinumab.),(Data Element Scope: ),(Inclusion Criteria: Includes single-ingredient canakinumab administed by subcutaneous injection.),(Exclusion Criteria: N/A)

Expansion
<<>>>
CodeDisplaySystem
1655971http://www.nlm.nih.gov/research/umls/rxnorm
1864324http://www.nlm.nih.gov/research/umls/rxnorm
1864326http://www.nlm.nih.gov/research/umls/rxnorm
1864325http://www.nlm.nih.gov/research/umls/rxnorm
1156606http://www.nlm.nih.gov/research/umls/rxnorm
853495http://www.nlm.nih.gov/research/umls/rxnorm
1864323http://www.nlm.nih.gov/research/umls/rxnorm
1655972http://www.nlm.nih.gov/research/umls/rxnorm
1655974http://www.nlm.nih.gov/research/umls/rxnorm
853491http://www.nlm.nih.gov/research/umls/rxnorm
1167137http://www.nlm.nih.gov/research/umls/rxnorm
853498http://www.nlm.nih.gov/research/umls/rxnorm
853494http://www.nlm.nih.gov/research/umls/rxnorm
1655975http://www.nlm.nih.gov/research/umls/rxnorm